Tong Ren Tang Technologies Co. Ltd. (1666.HK)
HKSE · HKD · Healthcare · Drug Manufacturers - General
HK$2.99 (-2.13%) as of
Key statistics
- Market cap
- 3.82B
- P/E (TTM)
- 11.06
- Forward P/E
- 6.35
- EPS (TTM)
- 0.270
- Dividend yield
- 6.94%
- 52-week range
- 2.955 – 4.950
- Beta
- 0.75
- Revenue (TTM)
- 5.77B
- Profit margin
- 5.32%
- Analyst target
- HK$5.41
- Volume
- 54.00k
About Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes Chinese medicine products in Mainland China and Hong Kong. It operates through three segments: The Company; Tong Ren Tang Chinese Medicine; and Others. The company develops, cultivates, processes, and purchases Chinese medicinal raw materials; retails and wholesales Chinese medicine products and healthcare products. It also offers ointments, healthcare products, tea drinks, food, foot care products, biological products, western medicine, and cosmetics. In addition, it provides medical research and development; advertisement; and Chinese medical consultations and treatments. Further, the company produces and processes biochemical products; extracts and processes plants; and offers medical services. Tong Ren Tang Technologies Co. Ltd. was founded in 1669 and is based in Beijing, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Beijing, China
- Employees
- 3,801
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.